Skip to main content

Lifecore Biomedical, Inc.

corporate_fare Company Profile

Lifecore Biomedical, Inc.

LFCR·NASDAQ·Life Sciences·CIK 0001005286

Lifecore Biomedical, Inc. is a contract development and manufacturing organization (CDMO) based in Chaska, Minnesota. The company specializes in the development, cGMP manufacturing, and aseptic filling of complex and highly viscous sterile injectable pharmaceutical drug and medical device products in syringes, vials, and cartridges. Lifecore is a leading U.S. manufacturer of pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA), utilizing a proprietary, fermentation-based HA process developed in 1981. They manufacture HA in bulk form and for use in formulated and filled syringes and vials for customer injectable products, which are used in ophthalmic and orthopedic applications, among others. Lifecore also develops highly viscous non-HA-based sterile injectable products with customers for various applications. The company's product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. Lifecore operates semi-automated Restricted Access Barrier Systems (RABS) and fully automated aseptic filling lines with isolators, supporting aseptic processing of both synthetic and biologic drug products. Manufacturing occurs across three cGMP facilities, where FDA-approved commercial drug and device products are produced. Lifecore holds certifications from regulatory agencies in Europe, Japan, Brazil, and the International Organization for Standardization (ISO). The company's HA capabilities were developed in the early 1980s, and its corporate name changed from Landec Corporation to Lifecore Biomedical, Inc. in 2022 to reflect its focus on the CDMO business.

Lifecore Biomedical, Inc. (NASDAQ:LFCR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for LFCR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for LFCR spans 8-K, PREM14A, SCHEDULE 13D/A, DEFA14A.

Recent high-impact activity:

  • Lifecore Q3 Revenue Falls 18.6% to $25.3M; $40.1M Net Loss Driven by Non-Cash Derivative Mark
  • Lifecore Proxy Sets Vote on $6.28 Cash Takeover; Go-Shop Ends With No Rival Bid
  • Wynnefield Locks Up 14.3% Stake Behind Webster Acquisition
  • Legion Partners Locks Up 17.3% Stake in Support of Webster Equity Merger
  • Lifecore Locks Up Activist Holders and Extends Alcon Deal in $6.28/Share Webster Buyout

Financial Snapshot

Fiscal year ended May 25, 2025
Revenue
$128.87M
Net Income
-$38.72M
Diluted EPS
-$1.27
Op. Cash Flow
-$206K
Free Cash Flow
-$13.62M
Gross Profit
$40.3M
Operating Income
-$17.25M
Cash & Equivalents
$8.27M
Total Debt
$133.87M
Debt / Equity
100.20×
Net Margin
-30.0%
Shares Outstanding
37.03M sh
Source: 10-K · filed 2025-08-07 · accession 0001005286-25-000108

Short Interest & Short Volume

3.52 days to cover

FINRA reported short interest of 1,722,308 shares in LFCR as of the October 30, 2026 settlement, a 4.5% decrease from the prior period — about 3.5 days to cover at its recent average daily volume. On November 20, 2026, 38.3% of LFCR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,722,308 shares as of October 30, 2026
Change vs prior period▼ 4.5%
Days to cover3.52 at avg daily volume of 489,149
Daily short volume (FINRA facilities)38.3% of 53,084 shares on November 20, 2026
5-day average short volume32.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for LFCR, detected from its recent SEC filings · based on capital-structure filings through 2026-06-05.

New Stock Incentive Plan Approved · Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$6.37
52-week range · as of 2026-11-04 $3.63 – $8.98
Market cap
$242.22M
Volume
218.7K (0.6× avg)
3-mo avg 383K
Live data · 2026-11-21 04:46 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed LFCR - Latest Insights

LFCR
Nov 04, 2026, 7:13 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.38
Real-time Price: $6.37 info
Change: -$0.0104 (-0.16%) info
Market Cap: $242.218M info
LFCR
Oct 30, 2026, 5:26 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $6.40
Real-time Price: $6.37 info
Change: -$0.030 (-0.47%) info
Market Cap: $242.218M info
LFCR
Sep 29, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.52
Real-time Price: $6.37 info
Change: -$0.150 (-2%) info
Market Cap: $242.218M info
LFCR
Sep 28, 2026, 5:41 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.62
Real-time Price: $6.37 info
Change: -$0.250 (-4%) info
Market Cap: $242.218M info
LFCR
Sep 28, 2026, 8:56 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $6.37 info
Change: +$2.07 (+48%) info
Market Cap: $242.218M info
LFCR
Sep 28, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $6.37 info
Change: +$2.07 (+48%) info
Market Cap: $242.218M info
LFCR
Sep 28, 2026, 8:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $6.37 info
Change: +$2.07 (+48%) info
Market Cap: $242.218M info
LFCR
Aug 05, 2026, 8:13 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.52
Real-time Price: $6.37 info
Change: +$1.85 (+41%) info
Market Cap: $242.218M info
LFCR
Aug 05, 2026, 7:20 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.52
Real-time Price: $6.37 info
Change: +$1.85 (+41%) info
Market Cap: $242.218M info
LFCR
Aug 05, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.52
Real-time Price: $6.37 info
Change: +$1.85 (+41%) info
Market Cap: $242.218M info
LFCR
Jul 02, 2026, 5:36 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $5.09
Real-time Price: $6.37 info
Change: +$1.28 (+25%) info
Market Cap: $242.218M info
LFCR
Jul 02, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.09
Real-time Price: $6.37 info
Change: +$1.28 (+25%) info
Market Cap: $242.218M info
LFCR
Jul 02, 2026, 5:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $5.09
Real-time Price: $6.37 info
Change: +$1.28 (+25%) info
Market Cap: $242.218M info
LFCR
Jun 15, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.64
Real-time Price: $6.37 info
Change: +$0.730 (+13%) info
Market Cap: $242.218M info
LFCR
Jun 05, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.63
Real-time Price: $6.37 info
Change: +$0.740 (+13%) info
Market Cap: $242.218M info
LFCR
Jun 02, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.97
Real-time Price: $6.37 info
Change: +$1.40 (+28%) info
Market Cap: $242.218M info
LFCR
May 06, 2026, 7:22 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.80
Real-time Price: $6.37 info
Change: +$1.57 (+33%) info
Market Cap: $242.218M info
LFCR
May 06, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.85
Real-time Price: $6.37 info
Change: +$1.52 (+31%) info
Market Cap: $242.218M info
LFCR
May 06, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.08
Real-time Price: $6.37 info
Change: +$1.29 (+25%) info
Market Cap: $242.218M info
LFCR
Mar 26, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.19
Real-time Price: $6.37 info
Change: +$2.18 (+52%) info
Market Cap: $242.218M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets